BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 18374759)

  • 1. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
    Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats.
    Liu XB; Wang JA; Ji XY; Yu SP; Wei L
    Stem Cell Res Ther; 2014 Sep; 5(5):111. PubMed ID: 25257482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
    Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
    Hu X; Xu Y; Zhong Z; Wu Y; Zhao J; Wang Y; Cheng H; Kong M; Zhang F; Chen Q; Sun J; Li Q; Jin J; Li Q; Chen L; Wang C; Zhan H; Fan Y; Yang Q; Yu L; Wu R; Liang J; Zhu J; Wang Y; Jin Y; Lin Y; Yang F; Jia L; Zhu W; Chen J; Yu H; Zhang J; Wang J
    Circ Res; 2016 Mar; 118(6):970-83. PubMed ID: 26838793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
    Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
    Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction].
    Maslov LN; Podoksenov IuK; Portnichenko AG; Naumova AV
    Vestn Ross Akad Med Nauk; 2013; (12):16-25. PubMed ID: 24741938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanently Hypoxic Cell Culture Yields Rat Bone Marrow Mesenchymal Cells with Higher Therapeutic Potential in the Treatment of Chronic Myocardial Infarction.
    Liu Y; Yang X; Maureira P; Falanga A; Marie V; Gauchotte G; Poussier S; Groubatch F; Marie PY; Tran N
    Cell Physiol Biochem; 2017; 44(3):1064-1077. PubMed ID: 29179177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazoxide preconditioning of endothelial progenitor cells improves their ability to repair the infarcted myocardium.
    Mehmood A; Ali M; Khan SN; Riazuddin S
    Cell Biol Int; 2015 Nov; 39(11):1251-63. PubMed ID: 26032287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
    Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
    Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.
    Bader AM; Klose K; Bieback K; Korinth D; Schneider M; Seifert M; Choi YH; Kurtz A; Falk V; Stamm C
    PLoS One; 2015; 10(9):e0138477. PubMed ID: 26380983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
    Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
    Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.
    Xing Y; Hou J; Guo T; Zheng S; Zhou C; Huang H; Chen Y; Sun K; Zhong T; Wang J; Li H; Wang T
    Stem Cell Res Ther; 2014 Nov; 5(6):130. PubMed ID: 25418617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats.
    Fang J; Chen L; Fan L; Wu L; Chen X; Li W; Lin Y; Wang W
    J Mol Cell Cardiol; 2011 Nov; 51(5):839-47. PubMed ID: 21763697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and osteogenesis in rabbit femoral head osteonecrosis.
    Fan L; Zhang C; Yu Z; Shi Z; Dang X; Wang K
    Bone; 2015 Dec; 81():544-553. PubMed ID: 26363339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF kappa B-dependent mechanism in a rat model of chronic myocardial infarction.
    Sasaki H; Ray PS; Zhu L; Otani H; Asahara T; Maulik N
    J Mol Cell Cardiol; 2001 Feb; 33(2):283-94. PubMed ID: 11162133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.